177 related articles for article (PubMed ID: 21338184)
1. Epidemiology of cancer of the liver and intrahepatic bile ducts in an Australian population.
Luke C; Price T; Roder D
Asian Pac J Cancer Prev; 2010; 11(6):1479-85. PubMed ID: 21338184
[TBL] [Abstract][Full Text] [Related]
2. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
Tischoff I; Tannapfel A
Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
[TBL] [Abstract][Full Text] [Related]
3. Time and deprivation trends in incidence of primary liver cancer subtypes in England.
Konfortion J; Coupland VH; Kocher HM; Allum W; Grocock MJ; Jack RH
J Eval Clin Pract; 2014 Aug; 20(4):498-504. PubMed ID: 24902884
[TBL] [Abstract][Full Text] [Related]
4. Descriptive epidemiology of bile duct carcinoma in Osaka.
Ikeda A; Miyashiro I; Nakayama T; Ioka A; Tabuchi T; Ito Y; Tsukuma H
Jpn J Clin Oncol; 2013 Nov; 43(11):1150-5. PubMed ID: 24014885
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiology of primary and secondary liver cancers].
Jepsen P; Kissmeyer-Nielsen P
Ugeskr Laeger; 2008 Apr; 170(16):1323-5. PubMed ID: 18433588
[TBL] [Abstract][Full Text] [Related]
6. Rising incidence of primary liver cancer in Brunei Darussalam.
Chong RJ; Abdullah MS; Hossain MM; Telisinghe PU; Chong VH
Asian Pac J Cancer Prev; 2013; 14(6):3473-7. PubMed ID: 23886131
[TBL] [Abstract][Full Text] [Related]
7. Increase in primary liver cancer in the UK, 1979-94.
Taylor-Robinson SD; Foster GR; Arora S; Hargreaves S; Thomas HC
Lancet; 1997 Oct; 350(9085):1142-3. PubMed ID: 9343506
[No Abstract] [Full Text] [Related]
8. [Increased incidence of hepatocellular and intrahepatic cholangiocellular carcinoma in northeast Germany].
Schurr R; Stölzel U; Schuppan D; Schwertner C; Steinberg J; Scherübl H
Dtsch Med Wochenschr; 2006 Jul; 131(30):1649-55. PubMed ID: 16850381
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of liver cancer: an overview.
Srivatanakul P; Sriplung H; Deerasamee S
Asian Pac J Cancer Prev; 2004; 5(2):118-25. PubMed ID: 15244512
[TBL] [Abstract][Full Text] [Related]
10. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
Jepsen P; Vilstrup H; Tarone RE; Friis S; Sørensen HT
J Natl Cancer Inst; 2007 Jun; 99(11):895-7. PubMed ID: 17551150
[TBL] [Abstract][Full Text] [Related]
11. Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: Demographics, pathology and survival.
Koea J; Phillips A; Lawes C; Rodgers M; Windsor J; McCall J
ANZ J Surg; 2002 Dec; 72(12):857-61. PubMed ID: 12485219
[TBL] [Abstract][Full Text] [Related]
12. Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.
Altekruse SF; Petrick JL; Rolin AI; Cuccinelli JE; Zou Z; Tatalovich Z; McGlynn KA
PLoS One; 2015; 10(3):e0120574. PubMed ID: 25837669
[TBL] [Abstract][Full Text] [Related]
13. Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor.
Garancini M; Goffredo P; Pagni F; Romano F; Roman S; Sosa JA; Giardini V
Liver Transpl; 2014 Aug; 20(8):952-9. PubMed ID: 24777610
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival.
Witjes CD; Karim-Kos HE; Visser O; van den Akker SA; de Vries E; Ijzermans JN; de Man RA; Coebergh JW; Verhoef C
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):450-7. PubMed ID: 22273986
[TBL] [Abstract][Full Text] [Related]
15. Double cancer, cholangiocellular and hepatocellular carcinomas, in the cirrhotic liver.
Yoshikawa T; Hirota S; Matsumoto S; Izaki K; Fukuda T; Sugimura K; Maeda S; Kitagaki H
Radiat Med; 2002; 20(1):33-6. PubMed ID: 12002601
[TBL] [Abstract][Full Text] [Related]
16. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States.
Welzel TM; McGlynn KA; Hsing AW; O'Brien TR; Pfeiffer RM
J Natl Cancer Inst; 2006 Jun; 98(12):873-5. PubMed ID: 16788161
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of cholangiocarcinoma.
Shaib Y; El-Serag HB
Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
[TBL] [Abstract][Full Text] [Related]
18. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.
McGlynn KA; Tarone RE; El-Serag HB
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1198-203. PubMed ID: 16775181
[TBL] [Abstract][Full Text] [Related]
19. Association of nonalcoholic fatty liver disease and liver cancer.
Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
[TBL] [Abstract][Full Text] [Related]
20. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study.
Sapisochin G; de Lope CR; Gastaca M; de Urbina JO; López-Andujar R; Palacios F; Ramos E; Fabregat J; Castroagudín JF; Varo E; Pons JA; Parrilla P; González-Diéguez ML; Rodriguez M; Otero A; Vazquez MA; Zozaya G; Herrero JI; Antolin GS; Perez B; Ciria R; Rufian S; Fundora Y; Ferron JA; Guiberteau A; Blanco G; Varona MA; Barrera MA; Suarez MA; Santoyo J; Bruix J; Charco R
Ann Surg; 2014 May; 259(5):944-52. PubMed ID: 24441817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
